Sign in to view content

Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial

Nancy M. Holekamp, MD, FASRS

Video
Published 2016

Related

Quantification of Capillary Nonperfusion in Diabetic Retinopathy Using Ultra-widefield Optical Coherence Tomography Angiography
Kasra Rezaei, M.D.
Annual Meeting Talks
2019
Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy
Michael J Allingham, MD, PhD
Annual Meeting Talks
2022
Comparing Rates of Vitrectomy in Proliferative Diabetic Retinopathy Patients Treated With Anti-VEGF or Panretinal Photocoagulation Monotherapy
Nadim M Rayess, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more